Brookstone Capital Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Brookstone Capital Management’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-62	Closed	-$1K	–	870
2022 Q3	$1K	Sell	62 -9	-13%	-$315	﹤0.01%	780
2022 Q2	$4K	Hold	71	–	–	﹤0.01%	755
2022 Q1	$9K	Hold	71	–	–	﹤0.01%	765
2021 Q4	$11K	Hold	71	–	–	﹤0.01%	746
2021 Q3	$35K	Hold	71	–	–	﹤0.01%	723
2021 Q2	$33K	Hold	71	–	–	﹤0.01%	710
2021 Q1	$36K	Buy	71 +24	+51%	+$12.4K	﹤0.01%	500
2020 Q4	$23K	Buy	47 +8	+21%	+$2.62K	﹤0.01%	468
2020 Q3	$11K	Hold	39	–	–	﹤0.01%	443
2020 Q2	$8K	Hold	39	–	–	﹤0.01%	358
2020 Q1	$5K	Hold	39	–	–	﹤0.01%	335
2019 Q4	$7K	Hold	39	–	–	﹤0.01%	416
2019 Q3	$6K	Hold	39	–	–	﹤0.01%	441
2019 Q2	$5K	Hold	39	–	–	﹤0.01%	440
2019 Q1	$7K	Hold	39	–	–	﹤0.01%	398
2018 Q4	$5K	Hold	39	–	–	﹤0.01%	308
2018 Q3	$6K	Hold	39	–	–	﹤0.01%	401
2018 Q2	$26K	Buy	+39	New	+$29.2K	﹤0.01%	365
2015 Q4	–	Sell	-3	Closed	-$3K	–	937
2015 Q3	$3K	Buy	+3	New	+$2.51K	﹤0.01%	1631

Other funds holding AMPE

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return

WWM

Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return

BJL

Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

ARG

Advisory Resource Group Tulsa, Oklahoma $665M AUM 29.27% 1-Year Est. Return

CCMW

Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Brookstone Capital Management's AMPE Position: Q4 2022 in Review

Brookstone Capital Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 62 shares — an estimated $1K sold.

Brookstone Capital Management first reported a position in AMPE in Q3 2015 and held it in 19 quarters. The position peaked at $36K in Q1 2021. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

Brookstone Capital Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
Brookstone Capital Management sold 62 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $1K.
Brookstone Capital Management first reported a position in Ampio Pharmaceuticals Inc. in Q3 2015 and held it in 19 quarters.
Brookstone Capital Management's Ampio Pharmaceuticals Inc. position peaked at $36K in Q1 2021.
32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on Brookstone Capital Management's 13F filing for Q4 2022, filed 9 Jan 2023.